A patient and public involvement (PPI) review exploring patient reported outcome measures in adult CAR T-cell therapy patients
Summary: Background & Aims: Chimeric Antigen Receptor (CAR) T-cell therapy is a novel anti-cancer treatment option for patients with refractory or relapsed haematological malignancies. Preliminary research shows a significant proportion of patients receiving CAR T-cell therapy develop malnu...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Clinical Nutrition Open Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667268523000414 |